Eric P A Van Dongen Selected Research

Gentamicins (Gentamicin)

10/2019

A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric P A Van Dongen Research Topics

Disease

3	Morbid Obesity 01/2022 - 03/2014
2	Body Weight (Weight, Body) 10/2019 - 03/2014
1	Infections 01/2022
1	Obesity 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Sepsis (Septicemia) 10/2019
1	Postoperative Hemorrhage 01/2019
1	Surgical Wound Infection 03/2014

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 03/2014
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022
1	FluoroquinolonesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AminoglycosidesIBA 10/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	Cefazolin (Ancef)FDA LinkGeneric 03/2014

Therapy/Procedure

1	Intravenous Administration 01/2022
1	Therapeutics 01/2022
1	Bariatric Surgery 10/2019